These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3946465)

  • 1. Chronic congestive heart failure. Where have we been? Where are we heading?
    Applefeld MM
    Am J Med; 1986 Feb; 80(2B):73-7. PubMed ID: 3946465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the management of chronic heart failure.
    Chatterjee K
    Prim Care; 1985 Mar; 12(1):117-42. PubMed ID: 3846305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Circulation; 1984 Dec; 70(6):1038-47. PubMed ID: 6388899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
    Klein NA; Siskind SJ; Frishman WH; Sonnenblick EH; LeJemtel TH
    Am J Cardiol; 1981 Jul; 48(1):170-5. PubMed ID: 7246440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New positive inotropic drugs for the treatment of congestive heart failure.
    Sonnenblick EH; Mancini DM; LeJemtel TH
    Am J Cardiol; 1985 Jan; 55(2):41A-44A. PubMed ID: 2981465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential therapy of heart insufficiency].
    Gilfrich HJ
    Fortschr Med; 1982 Nov; 100(43):1993-6. PubMed ID: 7152435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-appraisal of treatment of congestive heart failure.
    Shen WF
    Chin Med J (Engl); 1991 Jul; 104(7):607-13. PubMed ID: 1879224
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous use of amrinone for the treatment of the failing heart.
    Mancini D; LeJemtel T; Sonnenblick E
    Am J Cardiol; 1985 Jul; 56(3):8B-15B. PubMed ID: 2411122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digitalis in heart failure. Farewell to the foxglove?
    Sodums MT; Walsh RA; O'Rourke RA
    JAMA; 1981 Jul; 246(2):158-60. PubMed ID: 7241749
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term therapy of congestive heart failure and dilatative cardiomyopathy].
    Baur HR
    Schweiz Med Wochenschr; 1984 Jan; 114(3):66-9. PubMed ID: 6701489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy of congestive heart failure].
    Sasayama S
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1770-7. PubMed ID: 9410998
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical effects of intravenous amrinone in patients with congestive heart failure.
    Goldstein RA
    Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure.
    Gage J; Rutman H; Lucido D; LeJemtel TH
    Circulation; 1986 Aug; 74(2):367-73. PubMed ID: 3731427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of treatment on survival in congestive heart failure.
    Pitt B; Cohn JN; Francis GS; Kostis JB; Packer M; Pfeffer MA; Swedberg K; Yusuf S
    Clin Cardiol; 1992 May; 15(5):323-9. PubMed ID: 1623652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digitalis and other positive catecholamine-like inotropic agents in the management of congestive heart failure.
    Applefeld MM; Roffman DS
    Am J Med; 1986 Feb; 80(2B):40-5. PubMed ID: 3004211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology and current therapy of congestive heart failure due to idiopathic cardiomyopathy].
    Kambayashi M; Kumada T
    Nihon Rinsho; 1993 May; 51(5):1328-32. PubMed ID: 8101239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-response curves of positive inotropic agents before and after ouabain pretreatment.
    Brown L; Erdmann E
    Cardiovasc Res; 1985 May; 19(5):288-98. PubMed ID: 3995524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: therapeutic concepts of congestive heart failure.
    Haustein KO
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):273-81. PubMed ID: 1974888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE; Ziesche S; Carson PE; Conrad CH; Syat D; Cohn JN
    Am J Cardiol; 1996 May; 77(12):1078-82. PubMed ID: 8644661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.